Asthma Therapy™ Homeopathic Fast Dissolving Tablets

Manufacturer: TRP Company
Effective date: 2025-12-15
Label type: HUMAN OTC DRUG LABEL
Version: 6
Source: full-release
Hydrated at: 2026-06-01 02:35:48

Label at a glance#

ProductAsthma Therapy

Active ingredientSTRYCHNOS NUX-VOMICA SEED, ASPIDOSPERMA QUEBRACHO-BLANCO BARK, SULFUR, ARSENIC TRIOXIDE, HISTAMINE DIHYDROCHLORIDE, DERMATOPHAGOIDES PTERONYSSINUS, MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE

Label structure9 sections

Indications and uses

According to homeopathic indications, these ingredients provide temporary relief of Asthma and COPD like symptoms such as: • Difficulty Breathing • Inflammation in the airways • Coughing • Wheezing • Shortness of breath • Sensation of tightness of the chest • Congestion after a diagnosis of Asthma or COPD by a physician.

Dosage and administration

Suitable for adults and children 12 years and above. Dissolve entire tablet under tongue. Do not chew or swallow whole. Take 1 tablet 3 times a day or as directed by a physician. Use up to 6 times a day as needed. Take at least 10 minutes before or at least 10 minutes after eating or drinking. Children under the age of 12: consult a physician before use.

Contacts and useful links#

PhoneLabel contact888-969-6855

Label contents#

Full prescribing information#

OTC - ACTIVE INGREDIENT SECTION

Active Ingredients		Purpose
Arsenicum album HPUS	6c/12c/18c	Wheezing, Anxiety, Inflammation in the airways
Histaminum hydrochloricum HPUS	6c/12c/18c	Persistent, Dry, Fitful cough
House Dust Mite	6c/12c/18c	Allergies
Magnesia Phosphorica HPUS	6c/12c/18c	Tightness in chest, Spasmodic cough
Nux Vomica HPUS	6c/12c/18c	Shallow breathing, Dry hacking cough, Nervousness
Quebracho HPUS	6c/12c/18c	Difficulty breathing, Shortness of breath
Sulphur HPUS	6c/12c/18c	Difficult, Irregular respiration

The letters HPUS indicate that the components of this product are officially monographed in the Homeopathic Pharmacopoeia of the United States.

Uses

INDICATIONS & USAGE SECTION

Warnings

WARNINGS SECTION

USE ONLY AFTER DIAGNOSIS BY A PHYSICIAN.

This product is a not a fast acting (rescue) inhaler.
This product is intended to complement, not replace, standard medical treatment.
Initial worsening of symptoms may occur.
A physician should always be consulted to rule out serious causes.
In case of overdose, get medical help or contact a Poison Control Center right away.

Stop use and ask a doctor if:

You experience worsening symptoms.
If symptoms last longer than 7 days.

OTC - PREGNANCY OR BREAST FEEDING SECTION

If pregnant or breast-feeding, ask a health professional before use.

Directions

DOSAGE & ADMINISTRATION SECTION

Suitable for adults and children 12 years and above.
Dissolve entire tablet under tongue.
Do not chew or swallow whole.
Take 1 tablet 3 times a day or as directed by a physician.
Use up to 6 times a day as needed.
Take at least 10 minutes before or at least 10 minutes after eating or drinking.
Children under the age of 12: consult a physician before use.

Other information

SPL UNCLASSIFIED SECTION

Active ingredients are micro-diluted in accordance with the Homeopathic Pharmacopoeia of the United States and are therefore non-toxic with no known side effects.
Store in a cool dark location.

Inactive Ingredients

INACTIVE INGREDIENT SECTION

Advantol® 300, Lactose, Magnesium Stearate, Mannitol, Microcrystalline Cellulose.

OTC - QUESTIONS SECTION

For more information and to order related products call toll free: 888-969-6855 or trpcompany.com

Principal Display Panel

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

FDA Disclaimer: Claims based on traditional
homeopathic practice, not accepted medical
evidence. Not FDA evaluated.

Carton

Label

Product Linked Resources#

Resource, Code type, Value table
Resource	Code type	Value	Equivalent identifiers	Source image
Barcode	EAN-13	0858961001174	GTIN-13: 0858961001174 EAN-13: 0858961001174 GTIN-12: 858961001174 UPC-A: 858961001174 GTIN storage (14 digits): 00858961001174	TRP_NR_AT_FDT_70ct_CTN_3-18-24_r14_F.jpg

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
6e3c022f-0786-43f1-8857-edff89d5153f	Product name	1	20260309
95250459-30e4-45c1-b08a-993044f49109	Product name	2	20250805
63f39a63-5cd1-4016-bd86-2bbb0f6c3139	Product name	3	20240506
e5a77e9c-c528-733a-173d-914a234c024b	Product name	5	20240506
efd58652-cb8f-4018-91ca-4b0eb2ff729f	Product name	7	20240226
362d7abb-94e6-4c60-9a58-266894157713	Product name	1	20231023
e2db08c6-133f-4f4f-afb4-e90a2418d6f6	Product name	1	20230320
6bd95106-a412-1dad-b9cc-4cb74bfb27ce	Product name	2	20230315
9badc7be-250a-44ab-aa36-926af3f02679	Product name	1	20210527
a62a50ac-1535-4461-9768-8ae703e2e9fb	Product name	1	20210525
2641ccb3-721d-4fbf-9f2f-ca2f18157a62	Product name	3	20210309
11ed6f83-cdd2-4637-8379-b1a1d3ae3cde	Product name	1	20181101
7cda52fc-125f-421c-8fea-bc1974370c49	Product name	2	20180703
86c45a79-b9f0-4476-a27c-6e10db098497	Product name	1	20180125
26acd337-b838-40ac-bcbc-05c3b81c8712	Product name	1	20170323
d5e51f11-ad28-caa4-4b49-4143974782ad	Product name	1	20150831
290f523a-f9db-9774-b5a9-e1f908ac1782	Product name	1	20150828
e7e58cd3-cacb-49df-8d34-1ee335614abb	Product name	1	20150609
0ca1d589-929b-4b33-bc5b-1d84abdafa6a	Product name	1	20150324
fc363c46-397b-4476-ac0f-70e43e8e4592	Product name	1	20150324
6084a4f4-5437-c9a5-caec-5361ee075a59	Product name	1	20140508
90c5639a-61b0-88d6-ddcf-21888e94869a	Product name	1	20140508
9514609b-a2a9-f8ec-6ba6-3f8e5ee89877	Product name	1	20140508
bc07ef78-e82d-0c19-31f4-31f263780582	Product name	1	20140508
c6b65c52-69c7-df49-550a-a50c137f6218	Product name	1	20140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
17312-017-14	Asthma Therapy	70 in 1 BOTTLE	TABLET, ORALLY DISINTEGRATING	70		6
17312-017-14	Asthma Therapy	1 in 1 PACKAGE	TABLET, ORALLY DISINTEGRATING	1		6

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	SPL version
ARSENIC TRIOXIDE	ACTIVE INGREDIENT	S7V92P67HO	1
ASPIDOSPERMA QUEBRACHO-BLANCO BARK	ACTIVE INGREDIENT	52B1340190	1
DERMATOPHAGOIDES PTERONYSSINUS	ACTIVE INGREDIENT	57L1Z5378K	1
HISTAMINE DIHYDROCHLORIDE	ACTIVE INGREDIENT	3POA0Q644U	1
MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE	ACTIVE INGREDIENT	HF539G9L3Q	1
STRYCHNOS NUX-VOMICA SEED	ACTIVE INGREDIENT	269XH13919	1
SULFUR	ACTIVE INGREDIENT	70FD1KFU70	1
ARSENIC CATION (3+)	ACTIVE MOIETY	C96613F5AV	1
ASPIDOSPERMA QUEBRACHO-BLANCO BARK	ACTIVE MOIETY	52B1340190	1
DERMATOPHAGOIDES PTERONYSSINUS	ACTIVE MOIETY	57L1Z5378K	1
HISTAMINE	ACTIVE MOIETY	820484N8I3	1
MAGNESIUM CATION	ACTIVE MOIETY	T6V3LHY838	1
STRYCHNOS NUX-VOMICA SEED	ACTIVE MOIETY	269XH13919	1
SULFUR	ACTIVE MOIETY	70FD1KFU70	1
CELLULOSE, MICROCRYSTALLINE	INACTIVE INGREDIENT	OP1R32D61U	1
COPOVIDONE	INACTIVE INGREDIENT	D9C330MD8B	1
CROSPOVIDONE	INACTIVE INGREDIENT	68401960MK	1
LACTOSE	INACTIVE INGREDIENT	J2B2A4N98G	1
MAGNESIUM STEARATE	INACTIVE INGREDIENT	70097M6I30	1
MANNITOL	INACTIVE INGREDIENT	3OWL53L36A	1
SILICON DIOXIDE	INACTIVE INGREDIENT	ETJ7Z6XBU4	1
SORBITOL	INACTIVE INGREDIENT	506T60A25R	1

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 20 matching rows.

Asthma Therapy
ARSENIC TRIOXIDE - HISTAMINE DIHYDROCHLORIDE - DERMATOPHAGOIDES PTERONYSSINUS - MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE - STRYCHNOS NUX-VOMICA SEED - ASPIDOSPERMA QUEBRACHO-BLANCO BARK - SUPLHUR -
STRYCHNOS NUX-VOMICA SEED
ASPIDOSPERMA QUEBRACHO-BLANCO BARK
SULFUR
MANNITOL
SORBITOL
CROSPOVIDONE
CELLULOSE, MICROCRYSTALLINE
COPOVIDONE
SILICON DIOXIDE
LACTOSE
MAGNESIUM STEARATE
ARSENIC TRIOXIDE
ARSENIC CATION (3+)
HISTAMINE DIHYDROCHLORIDE
HISTAMINE
DERMATOPHAGOIDES PTERONYSSINUS
MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE
MAGNESIUM CATION

NDC Codes#

Product NDC, Package NDC table
Product NDC	Package NDC
17312-017	17312-017-14

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 15 matching rows.

Name, UNII, Kind table
Name	UNII	Kind
STRYCHNOS NUX-VOMICA SEED	269XH13919	ACTIB
ASPIDOSPERMA QUEBRACHO-BLANCO BARK	52B1340190	ACTIB
SULFUR	70FD1KFU70	ACTIB
MANNITOL	3OWL53L36A	IACT
SORBITOL	506T60A25R	IACT
CROSPOVIDONE	68401960MK	IACT
CELLULOSE, MICROCRYSTALLINE	OP1R32D61U	IACT
COPOVIDONE	D9C330MD8B	IACT
SILICON DIOXIDE	ETJ7Z6XBU4	IACT
LACTOSE	J2B2A4N98G	IACT
MAGNESIUM STEARATE	70097M6I30	IACT
ARSENIC TRIOXIDE	S7V92P67HO	ACTIB
HISTAMINE DIHYDROCHLORIDE	3POA0Q644U	ACTIB
DERMATOPHAGOIDES PTERONYSSINUS	57L1Z5378K	ACTIB
MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE	HF539G9L3Q	ACTIB

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 1 · 48 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredient	IID ingredient	UNII	Dosage form / route	Potency	Maximum daily exposure	Match
LACTOSE	LACTOSE	J2B2A4N98G	TABLET, DELAYED RELEASE / ORAL		160 mg	Exact identifier — unii+route 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	TABLET, EFFERVESCENT / ORAL	96.5 mg		Exact identifier — unii+route 36 equally ranked IID candidates
SORBITOL	SORBITOL	506T60A25R	TABLET, ORALLY DISINTEGRATING / ORAL		7 mg	Exact identifier — unii+route+dosage form 2 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	CAPSULE, COATED, EXTENDED RELEASE / ORAL	NA		Exact identifier — unii+route 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	CAPSULE / ORAL	530 mg		Exact identifier — unii+route 36 equally ranked IID candidates
MANNITOL	MANNITOL	3OWL53L36A	TABLET, ORALLY DISINTEGRATING / ORAL		4364 mg	Exact identifier — unii+route+dosage form 2 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	CAPSULE / ORAL	530 mg		Exact identifier — unii+route 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	TABLET / ORAL	2500 mg		Exact identifier — unii+route 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	POWDER, FOR SOLUTION / ORAL	NA		Exact identifier — unii+route 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	TABLET, CHEWABLE / ORAL		1412 mg	Exact identifier — unii+route 36 equally ranked IID candidates
COPOVIDONE	COPOVIDONE K25-31	D9C330MD8B	TABLET, ORALLY DISINTEGRATING / ORAL		35 mg	Exact identifier — unii+route+dosage form 2 equally ranked IID candidates
CELLULOSE, MICROCRYSTALLINE	MICROCRYSTALLINE CELLULOSE	OP1R32D61U	TABLET, ORALLY DISINTEGRATING / ORAL		1800 mg	Exact identifier — unii+route+dosage form 2 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	CAPSULE, DELAYED RELEASE / ORAL	231.84 mg		Exact identifier — unii+route 36 equally ranked IID candidates
SORBITOL	SORBITOL	506T60A25R	TABLET, ORALLY DISINTEGRATING / ORAL		7 mg	Exact identifier — unii+route+dosage form 2 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	TABLET, FILM COATED / ORAL	590 mg		Exact identifier — unii+route 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	CAPSULE, EXTENDED RELEASE / ORAL	120 mg		Exact identifier — unii+route 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	GRANULE, FOR SUSPENSION / ORAL	512.5 mg/5ml		Exact identifier — unii+route 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	SOLUTION / ORAL	1682 mg/15ml		Exact identifier — unii+route 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	SOLUTION / ORAL	1682 mg/15ml		Exact identifier — unii+route 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	CAPSULE, COATED, EXTENDED RELEASE / ORAL	NA		Exact identifier — unii+route 36 equally ranked IID candidates
MANNITOL	MANNITOL	3OWL53L36A	TABLET, ORALLY DISINTEGRATING / ORAL		4364 mg	Exact identifier — unii+route+dosage form 2 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	TABLET, FILM COATED / ORAL	590 mg		Exact identifier — unii+route 36 equally ranked IID candidates
COPOVIDONE	COPOVIDONE K25-31	D9C330MD8B	TABLET, ORALLY DISINTEGRATING / ORAL		35 mg	Exact identifier — unii+route+dosage form 2 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	TABLET, FILM COATED, EXTENDED RELEASE / ORAL		620 mg	Exact identifier — unii+route 36 equally ranked IID candidates
MAGNESIUM STEARATE	MAGNESIUM STEARATE	70097M6I30	TABLET, ORALLY DISINTEGRATING / ORAL		187 mg	Exact identifier — unii+route+dosage form 2 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	GRANULE, FOR SUSPENSION / ORAL	512.5 mg/5ml		Exact identifier — unii+route 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	CAPSULE, DELAYED RELEASE / ORAL	231.84 mg		Exact identifier — unii+route 36 equally ranked IID candidates
MAGNESIUM STEARATE	MAGNESIUM STEARATE	70097M6I30	TABLET, ORALLY DISINTEGRATING / ORAL		187 mg	Exact identifier — unii+route+dosage form 2 equally ranked IID candidates
CELLULOSE, MICROCRYSTALLINE	MICROCRYSTALLINE CELLULOSE	OP1R32D61U	TABLET, ORALLY DISINTEGRATING / ORAL		1800 mg	Exact identifier — unii+route+dosage form 2 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	TABLET, COATED / ORAL	332.05 mg		Exact identifier — unii+route 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	TABLET, COATED / ORAL	332.05 mg		Exact identifier — unii+route 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	CAPSULE, COATED PELLETS / ORAL	135.2 mg		Exact identifier — unii+route 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	TABLET, DELAYED RELEASE / ORAL		160 mg	Exact identifier — unii+route 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	TABLET / ORAL	2500 mg		Exact identifier — unii+route 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	POWDER, FOR SOLUTION / ORAL	NA		Exact identifier — unii+route 36 equally ranked IID candidates
SILICON DIOXIDE	SILICON DIOXIDE	ETJ7Z6XBU4	TABLET, ORALLY DISINTEGRATING / ORAL		68 mg	Exact identifier — unii+route+dosage form 2 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	TABLET, CHEWABLE / ORAL		1412 mg	Exact identifier — unii+route 36 equally ranked IID candidates
SILICON DIOXIDE	SILICON DIOXIDE	ETJ7Z6XBU4	TABLET, ORALLY DISINTEGRATING / ORAL		68 mg	Exact identifier — unii+route+dosage form 2 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	CONCENTRATE / ORAL	NA		Exact identifier — unii+route 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	CAPSULE, COATED PELLETS / ORAL	135.2 mg		Exact identifier — unii+route 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	TABLET, EFFERVESCENT / ORAL	96.5 mg		Exact identifier — unii+route 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	TABLET, SUGAR COATED / ORAL	NA		Exact identifier — unii+route 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	TABLET, SUGAR COATED / ORAL	NA		Exact identifier — unii+route 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	TABLET, EXTENDED RELEASE / ORAL	400 mg		Exact identifier — unii+route 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	CAPSULE, EXTENDED RELEASE / ORAL	120 mg		Exact identifier — unii+route 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	TABLET, FILM COATED, EXTENDED RELEASE / ORAL		620 mg	Exact identifier — unii+route 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	CONCENTRATE / ORAL	NA		Exact identifier — unii+route 36 equally ranked IID candidates
LACTOSE	LACTOSE	J2B2A4N98G	TABLET, EXTENDED RELEASE / ORAL	400 mg		Exact identifier — unii+route 36 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Asthma Therapy	ARSENIC TRIOXIDE - HISTAMINE DIHYDROCHLORIDE - DERMATOPHAGOIDES PTERONYSSINUS - MAGNESIUM PHOSPHATE, DIBASIC TRIHYDRATE - STRYCHNOS NUX-VOMICA SEED - ASPIDOSPERMA QUEBRACHO-BLANCO BARK - SUPLHUR -	TRP Company	07d2988b-5012-481c-9b48-a709c33d2979	2025-12-15	Warnings	Exact identifier ndc (package): 17312-017-14 ndc (product): 17312-017 ndc11 (package): 17312001714 spl id: 4604ca9e-7244-adfd-e063-6394a90afa65 spl set id: 07d2988b-5012-481c-9b48-a709c33d2979

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.